Different Phenotypes at Onset in Neuromyelitis Optica Spectrum Disorder Patients with Aquaporin-4 Autoimmunity-Reference-Cited by-同舟云学术

Different Phenotypes at Onset in Neuromyelitis Optica Spectrum Disorder Patients with Aquaporin-4 Autoimmunity

Published:2017-02-28 Issue: Volume:8 Page:
ISSN:1664-2295
Container-title:Frontiers in Neurology
language:
Short-container-title:Front. Neurol.

Author:

Long Youming,Liang Junyan,Wu Linzhan,Lin Shaopeng,Gao Cong,Chen Xiaohui,Qiu Wei,Yang Yu,Zheng Xueping,Yang Ning,Gao Min,Chen Yaotang,Wang Zhanhang,Su Quanxi

Funder

Natural Science Foundation of Guangdong Province

Guangdong Science and Technology Department

Publisher

Frontiers Media SA

Subject

Clinical Neurology,Neurology

Reference29 articles.

1. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis;Lennon;Lancet,2004

2. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders;Wingerchuk;Neurology,2015

3. Neuromyelitis optica and the evolving spectrum of autoimmune aquaporin-4 channelopathies: a decade later;Pittock;Ann N Y Acad Sci,2016

4. AQP4 antibody serostatus: is its luster being lost in the management and pathogenesis of NMO;Fujihara;Neurology,2013

5. The spectrum of neuromyelitis optica;Wingerchuk;Lancet Neurol,2007

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characteristics of recurrence in area postrema-onset NMO spectrum disorder - a retrospective cohort study;BMC Neurology;2024-05-21

2. Clinical features and prognosis of Tibetan patients with neuromyelitis optica spectrum disorder are different from those of Han Chinese patients;Journal of Neuroimmunology;2024-03

3. Aligning payer and provider strategies with the latest evidence to optimize clinical outcomes for patients with neuromyelitis optica spectrum disorder;Journal of Managed Care & Specialty Pharmacy;2022-12

4. The description of neuromyelitis optica spectrum disorder: Patient registry in Yangtze River Delta area of China;Multiple Sclerosis and Related Disorders;2022-10

5. Area Postrema Syndrome in Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy;Neurology - Neuroimmunology Neuroinflammation;2022-09-26